Hopeful that lead compound will be found to reduce severity and duration of covid-19 infection
Algernon Pharmaceuticals is a clinical stage drug repurposing company. On March 6th, 2020, the company announced that it was going to explore the…
Read More...
Browsing Tag
coronavirus treatment
Algernon Pharmaceuticals: Next Phase Study of Ifenprodil for COVID-19
About to begin a phase 2b/3 multinational study of Ifenprodil
Algernon Pharmaceuticals is a drug repurposing company.…
FSD Pharma: Developing its PEA Compound to Treat COVID-19
Drug with properties to reduce chronic inflammation
FSD Pharma is a specialty biotech pharmaceutical R&D company. FSD…
FDA Approves FSD Pharma to Submit I.N.D. for Compound to Treat Covid-19…
Positive results in Phase 1 human safety study
FSD Pharma is a specialty biotech pharmaceutical R&D company. Further,…
News Alert: FSD Pharma – FDA Approval to Submit I.N.D. Application for…
The FDA approved FSD Pharma to submit an Investigational New Drug (I.N.D.) application
FSD Pharma is a specialty biotech…
Algernon: Working on COVID-19 & Acute Lung Injury Treatment
Expanding the study of its re-purposed drug NP- 120
Algernon Pharmaceuticals is a clinical stage pharmaceutical development…
